The relationship of estrogen receptor status to DNA ploidy in breast cancer

Atsuo Tsuchiya; Mitsuhiro Nihei; Yoshiro Ando; Shinichi Suzuki; Izo Kimijima; Rikiya Abe

doi:10.1007/bf00311332

journal article Jan 01, 1992

The relationship of estrogen receptor status to DNA ploidy in breast cancer

Atsuo Tsuchiya Mitsuhiro Nihei Yoshiro Ando Shinichi Suzuki Izo Kimijima Rikiya Abe

Surgery Today Vol. 22 No. 2 pp. 105-109 · Springer Science and Business Media LLC

View at Publisher Save 10.1007/bf00311332

Topics

No keywords indexed for this article. Browse by subject →

References

30

[1]

McGuire WL, Osborne CK, Clark GM, Knights WA (1982) Steroid hormone receptors and carcinoma of the breast. Am J Physiol 243:99?102

[2]

Jensen EV (1977) Estrogen receptors in human cancer. JAMA 238:59?60 10.1001/jama.1977.03280010059026

[3]

McGuire WL, Dressler LG (1985) Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients. J Natl Cancer Invest 75:405?410

[4]

Kute TE, Muss HB, Hopkins M, Marshall R, Case D, Kammire L (1985) Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer. Breast Cancer Res Treat 6:113?121 10.1007/bf02235742

[5]

von Rosen A, Rutqvist LE, Carstensen J, Fallenius A, Skoog L, Auer G (1989) Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content. Breast Cancer Res Treat 13:23?32 10.1007/bf01806547

[6]

McGuire WL, DeLaGarza M (1978) Improved sensitivity in the measurement of estrogen receptor in human breast cancer. J Clin Endocr 37:986?989 10.1210/jcem-37-6-986

[7]

Schutte B, Reynders MMJ, Bosman FT, Blijham GH (1985) Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry 6:26?30 10.1002/cyto.990060106

[8]

Japanese Breast Cancer Society (1989) The general rules for clinical and pathological recording of breast cancer. Jpn J Surg 19:612?632 10.1007/bf02471672

[9]

Guazzi A, Bozzetti C, Riva MI, Zaffe D, Coccni G (1985) Relationship between estrogen receptor concentration and cytomorphometry in breast cancer. Cancer 56:1972?1976 10.1002/1097-0142(19851015)56:8<1972::aid-cncr2820560814>3.0.co;2-p

[10]

Larsimont D, Kiss R, d'Olne D, de Launoit Y, Mattheiem WH, Paridaens R, Pasteels J-L, Gompel C (1989) Correlation between nuclear cytomorphometric parameters and estrogen receptor levels in breast cancer. Cancer 63:2162?2168 10.1002/1097-0142(19890601)63:11<2162::aid-cncr2820631116>3.0.co;2-j

[11]

Clark GM, Osborne CK, McGuire WL (1984) Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J Clin Oncol 2:1102?1109 10.1200/jco.1984.2.10.1102

[12]

Thorpe SM, Roe C, Rasmussen BB, Mouridsen HT, Bayer T, Keiding N (1987) Prognostic value of steroid hormone receptors: Multivariate analysis of systemically untreated patients with node negative primary breast cancer. Cancer Res 47:6126?6133

[13]

Moolgavkar SH, Day NE, Stevens RG (1980) Two stage model for carcinogenesis: Epidermiology of breast cancer in females. J Natl Cancer Invest 65:559?569

[14]

McCarty, KS, Jr, Barton TK, Fetter BF, Woodard BH, Mossler JA, Reeves W, Daly J, Wilkinson WE, McCarty KS Sr (1980) Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma. Cancer 46:2851?2858 10.1002/1097-0142(19801215)46:12+<2851::aid-cncr2820461424>3.0.co;2-k

[15]

Nishi T, Okajima K, Fujiwara A, Sekimoto T, Kurokawa A (1984) Relation between hormone receptors in human breast cancer and nuclear grade (in Japanese with English abstract) Nippon Gan Chiryo Gakkai Zasshi (J Jpn Soc Cancer Ther) 19:2172?2178

[16]

Antoniades K, Spector H (1979) Correlation of estrogen receptor levels with histology and cytomorphology in human mammary cancer. Am J Clin Pathol 71:497?503 10.1093/ajcp/71.5.497

[17]

Fisher ER, Osborne CK, MuGuire WL, Redmond C, Knight WA, Fisher B, Bannayan G, Walder A, Gregory EJ, Jacobson A, Queen DM, Benett DE, Ford HC (1981) Correlation of primary breast cancer histopathology and estrogen receptor content. Breast Cancer Res Treat 1:37?41 10.1007/bf01807890

[18]

Cornelisse CJ, van de Velde CJH, Caspers RJC, Moolenaar AJ, Hermans J (1987) DNA ploidy and survival in breast cancer patients. Cytometry 8:225?234 10.1002/cyto.990080217

[19]

Dressler LG, Seamer LC, Owens MA, Clark GM, McGuire WL (1988) DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 61:420?427 10.1002/1097-0142(19880201)61:3<420::aid-cncr2820610303>3.0.co;2-0

[20]

Meyer JS, Rao BR, Stevens SC, White WL (1977) Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication. Cancer 40:2290?2298 10.1002/1097-0142(197711)40:5<2290::aid-cncr2820400541>3.0.co;2-t

[21]

Silvestrini R, Paidone MG, Fronzo GD (1979) Relationship between proliferative activity and estrogen receptors in breast cancer. Cancer 44:665?670 10.1002/1097-0142(197908)44:2<665::aid-cncr2820440237>3.0.co;2-n

[22]

Caldarola L, Volterrani P, Caldarola B, Lai M, Jayme A, Gaglia P (1986) The influence of hormone receptors and hormonal adjuvant therapy or disease-free survival in breast cancer: A multifactorial analysis. Eur J Cancer Clin Oncol 22:151?155 10.1016/0277-5379(86)90024-6

[23]

Haybittle JL, Blamey RW, Elston CW, Johnson J, Doyle PJ, Campbell FC, Nicholson RI, Griffiths K (1982) A prognostic index in primary breast cancer. Br J Cancer 45:361?366 10.1038/bjc.1982.62

[24]

Mason B, Holdaway IM, Mullins P, Yee LH, Kay RG (1983) Progesterone and estrogen receptors as prognostic variables in breast cancer. Cancer Res 43:2985?2990

[25]

Chevallier B, Heintzmann F, Mosseri V, Dauce JP, Bastit P, Graic Y, Brunelle P, Basuyau JP, Comoz M, Asselain B (1988) Prognostic value of estrogen and progesterone receptors in operable breast cancer. Cancer 62:2517?2524 10.1002/1097-0142(19881215)62:12<2517::aid-cncr2820621211>3.0.co;2-9

[26]

Nihei M, Tsuchiya A, Kimijima I, Suzuki S, Rokkaku Y, Nomizu T, Abe R (1989) A study of the number of binding sites of estrogen receptors as a malignancy factor in primary breast cancer (in Japanese with English abstract). Nippon Gan Chirhyo Gakkai Zasshi (J Jpn Soc Cancer Ther) 24:1585?1591

[27]

LeClerq G, Heuson JC, Deboel MC, Mattheiem WH (1975) Oestrogen receptors in breast cancer: A changing concept. Br Med J 1:185?189 10.1136/bmj.1.5951.185

[28]

Reiner A, Reiner G, Spone J, Schemper M, Holzner JH (1988) Histological characterization of human breast cancer in correlation with estrogen receptor status. Cancer 61:1149?1154 10.1002/1097-0142(19880315)61:6<1149::aid-cncr2820610615>3.0.co;2-z

[29]

Helin HJ, Helle MJ, Kallioniemi O-P, Isola JJ (1989) Immunohistochemical determination of estrogen and progesterone receptors in human breast cancer. Cancer 63:1761?1767 10.1002/1097-0142(19900501)63:9<1761::aid-cncr2820630918>3.0.co;2-3

[30]

Courdi A, Hery M, Chauvel P, Gioanni J, Namer M, Demard F (1988) Prognostic value of continuous variables in breast cancer and head and neck cancer. Dependence on the cut-off level. Br J Cancer 58:88?90 10.1038/bjc.1988.169

Metrics

5

Citations

30

References

Details

Published: Jan 01, 1992
Vol/Issue: 22(2)
Pages: 105-109
License: View

Authors

Cite This Article

Atsuo Tsuchiya, Mitsuhiro Nihei, Yoshiro Ando, et al. (1992). The relationship of estrogen receptor status to DNA ploidy in breast cancer. Surgery Today, 22(2), 105-109. https://doi.org/10.1007/bf00311332

The relationship of estrogen receptor status to DNA ploidy in breast cancer

You May Also Like